AboutValuesWhy OA.mg?OA.mg PremiumExploreDataContact
Chrome ExtensionScholarMindChatGPT Plugin
ϟ
 
DOI: 10.1016/j.breast.2011.02.014
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

Silvia Dellapasqua,M. Mazza,Débora Rosa,R. Ghisini,Eloise Scarano,Rosalba Torrisi,Patrick Maisonneuve,Giuseppe Viale,Enrico Cassano,Giulia Veronesi,Alberto Luini,Aron Goldhirsch,Marco Colleoni

Medicine
Cyclophosphamide
Doxorubicin
2011
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    “Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer” is a paper by Silvia Dellapasqua M. Mazza Débora Rosa R. Ghisini Eloise Scarano Rosalba Torrisi Patrick Maisonneuve Giuseppe Viale Enrico Cassano Giulia Veronesi Alberto Luini Aron Goldhirsch Marco Colleoni published in 2011. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.
    OA.mgAbout UsOur ValuesWhy OA.mg? OA.mg PremiumChrome ExtensionChatGPT PluginPublic RoadmapChangelogContact UsFeedback?
    Privacy PolicyTerms of ServiceRefund Policy
    ContentOA.mg CoverageTop ListsOpen Access JournalsTopicsBlog
    ExploreGeographyEngineeringPoliSciGeologyPhilosophySociologyArtHistoryMathematicsPhysics
     PsychologyComputer ScienceBusinessEnvironmental ScienceChemistryMaterials ScienceMedicineBiologyEconomics
    OA.mg is built in Stockholm, London, and Seoul. We work hand in hand with the scientific community to advance the cause of Open Access. Feedback makes us better.